A new challenge for the neuroradiologist: MR recognition of mitochondrial dysfunction in children born of HIV-seropositive mothers on antiretroviral therapy

American Journal of Neuroradiology

Volumn 26, Issue 4, 2005, Pages 687-689

  Post, M Judith Donovan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS ZIDOVUDINE; MITOCHONDRIAL DNA; ZIDOVUDINE;

BRAIN DISEASE; CELL DAMAGE; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT DISEASE; LONG TERM CARE; MEDICAL SPECIALIST; MORTALITY; NEUROIMAGING; NEURORADIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOLOGIST; VIRUS TRANSMISSION; WHITE MATTER;

ANTI-HIV AGENTS; HIV SEROPOSITIVITY; HUMANS; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MOTHERS; ZIDOVUDINE;

EID: 30544451308     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Blanche OO, et al. Cerebral magnetic resonance imaging in children born to HIV seropositive mothers and perinatally exposed to zidovudine. AJNR Am J Neuroradiol 2004; this issue
2. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J Med 1994;331:1173-1118
3. Taylor GP, Low-Beer N. Antiretroviral therapy in pregnancy: a focus on safety. Drug Safe 2001;24:683-702
4. Blanche S, Rouzioux C, Moscato ML, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type I: HIV infection in newborns French collaborative study group. N Engl J Med 1989;320:1643-1648
5. Barret B, Tardieu M, Rustin P, et al. Mitochondrial dysfunction in HIV uninfected children. AIDS 2003;17:1769-1785
6. Gerschenson M, Erhart SW, Paik CY, et al. Fetal mitochondrial heart and skeletal muscle damage in erythrocebus patas monkeys exposed to in utero to 3′-azido-3′-deoxythymidine. AIDS Res Hum Retrivuruses 2000;16:635-644
7. Munoz A, Mateos F, Simon R, et al. Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients. Neuroradiology 1999;41:920-928
8. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084-1089
9. Culnane M, Fowler M, Lee SS, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women: Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 1999;281:151-157
10. Perinatal Safety Review Working Group. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr 2000;25:261-268
11. Shiramizu B, Shikuma KM, Kanemoto L, et al. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 2003;32:370-374
12. Mantovani A, Calamandrei G. Delayed developmental effects following prenatal exposure to drugs. Curr Pharm Des 2001;7:859-880
13. Poirier MC, Divi RL, Al-Harthi L, et al. Long-term mitochondrial toxicity in HPV- uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr 2003;33:175-183